Treat-to-target in pediatric rheumatic diseases
S Rosina, AI Rebollo-Giménez, A Consolaro… - Current Rheumatology …, 2023 - Springer
Abstract Purpose of Review To summarize the current evidence on the adoption of the treat-
to-target (T2T) strategy in pediatric rheumatic diseases (PRD). Recent Findings The recent …
to-target (T2T) strategy in pediatric rheumatic diseases (PRD). Recent Findings The recent …
MicroRNAs in Juvenile Idiopathic Arthritis: State of the Art and Future Perspectives
Simple Summary Juvenile Idiopathic Arthritis (JIA) is a chronic pediatric arthritis and an
important cause of children's disabilities. Despite major therapeutic advancements achieved …
important cause of children's disabilities. Despite major therapeutic advancements achieved …
Proteomic profiling of extracellular vesicles in synovial fluid and plasma from Oligoarticular Juvenile Idiopathic Arthritis patients reveals novel immunopathogenic …
Introduction New early low-invasive biomarkers are demanded for the management of
Oligoarticular Juvenile Idiopathic Arthritis (OJIA), the most common chronic pediatric …
Oligoarticular Juvenile Idiopathic Arthritis (OJIA), the most common chronic pediatric …
[HTML][HTML] Extracellular vesicle‐derived microRNAs as potential biomarkers in oligoarticular juvenile idiopathic arthritis patients: methodological challenges and new …
F Raggi, D Cangelosi, A Consolaro… - Clinical and …, 2022 - ncbi.nlm.nih.gov
Dear Editor, Oligoarticular juvenile idiopathic arthritis (OJIA) is the most common chronic
paediatric arthritis in Western countries and a major cause of childhood disability. 1 Early …
paediatric arthritis in Western countries and a major cause of childhood disability. 1 Early …
Effects of a home-based exercise combined yoga and resistance training in enthesitis-related arthritis in China: study protocol for a randomised controlled trial
M Zhang, J Li, Y Su, G Guo, N Chen - BMJ open, 2024 - bmjopen.bmj.com
Introduction Enthesitis-related arthritis (ERA) is a category of juvenile idiopathic arthritis
(JIA). The complications of JIA include pain, muscle weakness, limited movement and …
(JIA). The complications of JIA include pain, muscle weakness, limited movement and …
Assessment of serum neopterin and calprotectin as biomarkers for subclinical inflammation in patients with familial Mediterranean fever
D Tezcan, DE Onmaz, A Sivrikaya, S Hakbilen… - Irish Journal of Medical …, 2023 - Springer
Abstract Background Familial Mediterranean fever (FMF) is the most common
autoinflammatory disease characterized by short, repeated, and self-limiting attacks of fever …
autoinflammatory disease characterized by short, repeated, and self-limiting attacks of fever …
Serum calprotectin a potential biomarker in juvenile idiopathic arthritis: A meta-analysis
E Altobelli, PM Angeletti, R Petrocelli… - Journal of Clinical …, 2021 - mdpi.com
Juvenile idiopathic arthritis (JIA) is the most common inflammatory chronic disease affecting
children and adolescents. Today, there are no specific biomarkers of inflammation …
children and adolescents. Today, there are no specific biomarkers of inflammation …
Peripheral blood regulatory T cells and disease activity, quality of life, and outcomes in children with juvenile idiopathic arthritis
N Quilis, P Mesa-del-Castillo Bermejo, P Boix… - Pediatric …, 2024 - Springer
Objectives To measure regulatory T cell (Treg) levels in the peripheral blood of children with
juvenile idiopathic arthritis (JIA) and analyse the association of this measure with disease …
juvenile idiopathic arthritis (JIA) and analyse the association of this measure with disease …
Emerging therapies for juvenile arthritis: agents in early clinical trials
Introduction Juvenile idiopathic arthritis (JIA) is the most common chronic inflammatory
rheumatic condition in childhood. The management of JIA has been revolutionized thanks to …
rheumatic condition in childhood. The management of JIA has been revolutionized thanks to …
[HTML][HTML] Associations of C reactive protein to albumin ratio, neutrophil to lymphocyte ratio, platelet to lymphocyte ratio with disease activity in patients with juvenile …
G Di Donato, M Attanasi, D Mariarita d'Angelo… - BMC rheumatology, 2024 - Springer
Introduction Recent works in the scientific literature reported the role of C reactive protein to
albumin ratio (CAR), neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio …
albumin ratio (CAR), neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio …